This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Only 2018 featured a higher number of drug approvals.
The CDC sent a health alert over a shortage of nirsevimab, used to treat RSV.
